Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Temporally Splitting Ovarian Stimulation and Embryo Transfer

This study has been completed.
Sponsor:
Information provided by:
University of Luebeck
ClinicalTrials.gov Identifier:
NCT00795041
First received: November 20, 2008
Last updated: October 15, 2010
Last verified: November 2008
  Purpose

The purpose of this study is to explore the concept of temporally splitting ovarian stimulation and embryo transfer.


Condition
Splitting of Ovarianstimulation and Embryotransfer

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Temporally Splitting Ovarian Stimulation and Embryo Transfer

Further study details as provided by University of Luebeck:

Primary Outcome Measures:
  • Ongoing pregnancy rate [ Time Frame: November 2008- May 2009 ] [ Designated as safety issue: No ]

Enrollment: 10
Study Start Date: November 2008
Study Completion Date: September 2010
Primary Completion Date: June 2010 (Final data collection date for primary outcome measure)
Groups/Cohorts
1
10 women with indication for ART with ICSI or IVF

  Eligibility

Ages Eligible for Study:   18 Years to 36 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

women with indication for ART with ICSI or IVF

Criteria

Inclusion Criteria:

  • Indication for IVF/ICSI
  • Age 18-36 years
  • <= three earlier unsuccessful IVF/ICSI treatments with embryo transfer
  • BMI 20-30
  • Regular cycle with ovulation (28-35 days)
  • Progesterone >7ng/ml at the beginning of stimulation
  • Informed consents

Exclusion Criteria:

  • PCOS (polycystic ovarian syndrome
  • Endometrioses >= grade 3
  • Known poor response syndrome
  • History of ovariectomy
  • Severe endocrinopathie
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00795041

Locations
Germany
University Hospital of Schleswig Holstein, Campus Luebeck, Department of Obstetrics and Gynecology
Luebeck, Schleswig-Holstein, Germany, 23538
Sponsors and Collaborators
University of Luebeck
Investigators
Principal Investigator: Georg Griesinger, PD MD University of Schleswig-Holstein, Campus Luebeck, Department of Obstetrics and Gynecology
  More Information

No publications provided by University of Luebeck

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Buendgen N.; Griesinger G. PD Dr. med., University Hospital of SH, Campus Luebeck, Deparment of Obstetrics/Gynecology
ClinicalTrials.gov Identifier: NCT00795041     History of Changes
Other Study ID Numbers: TS1
Study First Received: November 20, 2008
Last Updated: October 15, 2010
Health Authority: Germany: Ministry of Health

Keywords provided by University of Luebeck:
vitrification
ovarian stimulation
reproductive medicine

ClinicalTrials.gov processed this record on November 27, 2014